Tamar Canello

Hebrew University of Jerusalem — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index484citations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prion Diseases and Protein Misfolding(8), Neurological diseases and metabolism(6), MicroRNA in disease regulation(5), Glioma Diagnosis and Treatment(5), Circular RNAs in diseases(4)

Publications22 total

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes
International Journal of Molecular Sciences·2022· 8 citedOpen Access
Androgen receptor: a potential therapeutic target for glioblastoma
Oncotarget·2018· 72 citedOpen Access
CSIG-24. ANDROGEN RECEPTOR IS A POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA
Neuro-Oncology·2017· 2 citedOpen Access
Correction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
PLoS Pathogens·2017· 4 citedOpen Access
Correction: Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrPSc
PLoS Pathogens·2017· 2 citedOpen Access
GENT-03. EXPRESSION LEVEL OF miRNAs ON CHROMOSOME 14q32.31 REGION CORRELATES WITH TUMOR AGGRESSIVENESS AND SURVIVAL OF GLIOBLASTOMA PATIENTS
Neuro-Oncology·2016Open Access
CSIG-13. ANDROGEN RECEPTOR IS INVOLVED IN GLIOBLASTOMA AND PRESENTS A POTENTIAL THERAPEUTIC TARGET
Neuro-Oncology·2016· 3 citedOpen Access
P08.08 Expression level of miRNAs on chromosome 14q32.31 region correlates with survival of glioblastoma patients
Neuro-Oncology·2016Open Access
Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients
Journal of Neuro-Oncology·2016· 24 cited
Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab
Journal of neurosurgery·2016· 59 cited
CBM-15DYNAMICS OF CIRCULATING HYPOXIA MEDIATED miRNAs AND TUMOR RESPONSE IN HIGH-GRADE GLIOMA PATIENTS TREATED WITH BEVACIZUMAB
Neuro-Oncology·2015· 2 citedOpen Access
GENO-23AMPLIFICATION OF CHROMOSOME Xq11.1 -Xq11.2 MIGHT PLAY A ROLE IN GLIOBLASTOMA
Neuro-Oncology·2015· 3 citedOpen Access
Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer
PLoS ONE·2014· 3 citedOpen Access
ET-09 * DECOY OLIGONUCLEOTIDE DERIVED FROM MGMT ENHANCER HAS AN ANTINEOPLASTIC ACTIVITY IN-VITRO AND IN-VIVO
Neuro-Oncology·2014Open Access
Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression
PLoS ONE·2013· 23 citedOpen Access
LAB-CELL BIOLOGY AND SIGNALING
Neuro-Oncology·2012· 2 citedOpen Access
Multiple Pathways for High Voltage‐Activated <scp>C</scp>a<sup>2+</sup> Influx in Anterior Pituitary Lactotrophs and Somatotrophs
Journal of Neuroendocrinology·2012· 3 cited
Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease
Neurobiology of Disease·2011· 25 citedOpen Access
Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
PLoS Pathogens·2011· 83 citedOpen Access
Oxidation of Helix-3 Methionines Precedes the Formation of PK Resistant PrPSc
PLoS Pathogens·2010· 54 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Iris Lavon(13), Ruth Gabizon(9), Hanna Charbit(8), Tal Shahar(7), Kati Frid(6), Bracha Zelikovitch(6), Anat Mordechai(5), Tali Siegal(5), Daniel Zrihan(5), Haim Ovadia(4), Alexander Lossos(4), Marı́a Gasset(4), Yael Friedman‐Levi(3), Dana Avrahami(3), Yakov Fellig(3), Stav Rabani(3), Jackob Moskovitz(3), Avital Granit(3), Sharona Elgavish(3), Zvi Ram(3)